キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/08/23 | 2,430 | 2,459 | 2,423 | 2,449 | +6 | +0.2% | 86,900 |
2022/08/22 | 2,418 | 2,443 | 2,382 | 2,443 | +41 | +1.7% | 185,900 |
2022/08/19 | 2,410 | 2,418 | 2,392 | 2,402 | -14 | -0.6% | 78,900 |
2022/08/18 | 2,439 | 2,439 | 2,411 | 2,416 | -36 | -1.5% | 63,800 |
2022/08/17 | 2,448 | 2,455 | 2,437 | 2,452 | +9 | +0.4% | 79,900 |
2022/08/16 | 2,450 | 2,452 | 2,426 | 2,443 | -5 | -0.2% | 98,600 |
2022/08/15 | 2,456 | 2,462 | 2,431 | 2,448 | +18 | +0.7% | 121,400 |
2022/08/12 | 2,432 | 2,453 | 2,417 | 2,430 | +1 | ±0% | 114,700 |
2022/08/10 | 2,445 | 2,450 | 2,415 | 2,429 | +6 | +0.2% | 119,800 |
2022/08/09 | 2,414 | 2,441 | 2,410 | 2,423 | +9 | +0.4% | 136,100 |
2022/08/08 | 2,410 | 2,422 | 2,388 | 2,414 | -21 | -0.9% | 170,500 |
2022/08/05 | 2,401 | 2,443 | 2,400 | 2,435 | +21 | +0.9% | 128,000 |
2022/08/04 | 2,459 | 2,468 | 2,400 | 2,414 | -59 | -2.4% | 168,200 |
2022/08/03 | 2,536 | 2,536 | 2,468 | 2,473 | -102 | -4% | 221,200 |
2022/08/02 | 2,800 | 2,840 | 2,572 | 2,575 | -223 | -8% | 261,400 |
2022/08/01 | 2,787 | 2,811 | 2,765 | 2,798 | -15 | -0.5% | 171,500 |
2022/07/29 | 2,910 | 2,910 | 2,801 | 2,813 | -76 | -2.6% | 180,100 |
2022/07/28 | 2,910 | 2,918 | 2,850 | 2,889 | -211 | -6.8% | 302,700 |
2022/07/27 | 3,115 | 3,125 | 3,085 | 3,100 | -10 | -0.3% | 64,500 |
2022/07/26 | 3,080 | 3,120 | 3,075 | 3,110 | +30 | +1% | 96,600 |
2022/07/25 | 3,070 | 3,105 | 3,045 | 3,080 | +50 | +1.7% | 189,100 |
2022/07/22 | 2,970 | 3,050 | 2,965 | 3,030 | +65 | +2.2% | 171,700 |
2022/07/21 | 2,955 | 2,966 | 2,888 | 2,965 | +60 | +2.1% | 112,700 |
2022/07/20 | 2,906 | 2,910 | 2,874 | 2,905 | +47 | +1.6% | 95,200 |
2022/07/19 | 2,839 | 2,863 | 2,794 | 2,858 | +24 | +0.8% | 107,000 |
2022/07/15 | 2,827 | 2,849 | 2,820 | 2,834 | +21 | +0.7% | 161,800 |
2022/07/14 | 2,807 | 2,825 | 2,799 | 2,813 | ±0 | ±0% | 75,000 |
2022/07/13 | 2,806 | 2,815 | 2,791 | 2,813 | +7 | +0.2% | 96,900 |
2022/07/12 | 2,758 | 2,834 | 2,758 | 2,806 | +40 | +1.4% | 176,000 |
2022/07/11 | 2,730 | 2,774 | 2,729 | 2,766 | +79 | +2.9% | 79,800 |
2022/07/08 | 2,676 | 2,711 | 2,634 | 2,687 | +10 | +0.4% | 113,100 |
2022/07/07 | 2,684 | 2,694 | 2,664 | 2,677 | +12 | +0.5% | 72,100 |
2022/07/06 | 2,606 | 2,671 | 2,606 | 2,665 | +38 | +1.4% | 80,700 |
2022/07/05 | 2,651 | 2,661 | 2,620 | 2,627 | -19 | -0.7% | 49,400 |
2022/07/04 | 2,657 | 2,672 | 2,635 | 2,646 | +21 | +0.8% | 35,500 |
2022/07/01 | 2,652 | 2,692 | 2,604 | 2,625 | -29 | -1.1% | 92,400 |
2022/06/30 | 2,639 | 2,667 | 2,635 | 2,654 | +31 | +1.2% | 90,600 |
2022/06/29 | 2,611 | 2,637 | 2,605 | 2,623 | -23 | -0.9% | 289,100 |
2022/06/28 | 2,576 | 2,648 | 2,563 | 2,646 | +80 | +3.1% | 136,700 |
2022/06/27 | 2,580 | 2,580 | 2,523 | 2,566 | +29 | +1.1% | 84,400 |
2022/06/24 | 2,539 | 2,550 | 2,509 | 2,537 | -13 | -0.5% | 94,400 |
2022/06/23 | 2,503 | 2,562 | 2,502 | 2,550 | +72 | +2.9% | 96,300 |
2022/06/22 | 2,462 | 2,501 | 2,459 | 2,478 | +27 | +1.1% | 135,300 |
2022/06/21 | 2,442 | 2,462 | 2,421 | 2,451 | +35 | +1.4% | 107,200 |
2022/06/20 | 2,418 | 2,444 | 2,402 | 2,416 | +35 | +1.5% | 98,300 |
2022/06/17 | 2,355 | 2,391 | 2,342 | 2,381 | -17 | -0.7% | 132,200 |
2022/06/16 | 2,412 | 2,426 | 2,387 | 2,398 | -2 | -0.1% | 55,900 |
2022/06/15 | 2,436 | 2,451 | 2,394 | 2,400 | -50 | -2% | 75,500 |
2022/06/14 | 2,420 | 2,475 | 2,420 | 2,450 | +1 | ±0% | 101,200 |
2022/06/13 | 2,418 | 2,466 | 2,418 | 2,449 | -11 | -0.4% | 64,900 |
751~
800
件表示中 / 3783件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 447,000円 | +3.6% | - | 2.68% | 15.06倍 | 0.89倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
日本新薬 | 329,300円 | +3.6% | -15.3% | 3.77% | 9.25倍 | 0.90倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
ペプチド | 173,400円 | +5.0% | +1.5% | 0.00% | 14.84倍 | 4.18倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
サンバイオ | 239,300円 | - | - | 0.00% | - | 110.84倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
科研薬 | 389,900円 | -6.4% | -71.8% | 4.87% | 43.42倍 | 0.97倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム